MedPath

To study the efficacy of Yastimadhu Daruharidra Kwath Aschyotana and opticure eye drop in management of Sirotpat

Phase 3
Not yet recruiting
Conditions
Other acute conjunctivitis,
Registration Number
CTRI/2022/02/040490
Lead Sponsor
Tilak Ayurveda Mahavidyalaya Pune
Brief Summary

We came across number of patient of sirotpat/ simple hyperaemia of conjunctiva in day to day practice. Its incidence is increasing due to use of small screen such as mobile, computers such bright light objects, major air pollutants, poor hygienic condition all these causes are responsible for the   hyperaemia of conjunctiva. In modern medicine astringent eye drops is only treatment of hyperaemia. But it gives only symptomatic relief for some days and recurrence of hyperaemia is more so aschyotan is specially used in sirotpat. Aschyotan is more convenient and acceptable mode for local instillation of drug.

Yastimadhu churna is madhur rasa and sheeta viryatmak and daruharidra churna is katu tikta rasa and ushna viryatmak. So its action mainly on pitta and rakta dosha. Its decoction having cooling and astringent property. So it constrict the dilated vessels of conjunctiva in simple hyperaemia.

In reference to this the study has been undertaken.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Patient suffering from Sirotpat having at least 3 classical symptoms of sirotpat 1.
  • Sirajaladarshan 3.
  • Daha (burning sensation) 4.
Exclusion Criteria
  • 1.Patient with episcleritis, corneal injury, corneal ulcer, keratitis, iridocyclitis 2.Immunocompromised patients 3.
  • Patients with contagious diseases, malignancies.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the efficacy of Yastimadhu Daruharidra Kwath Aschyotana and opticure eye drop in the management of Sirotpat7 to 10 days
Secondary Outcome Measures
NameTimeMethod
To compare the effect of yastimadhu daruharidra kwath aschyotana and opticure eye drop.7to 10 days

Trial Locations

Locations (1)

Seth Tarachand Ramnath Charitable Ayurved Hospital

🇮🇳

Pune, MAHARASHTRA, India

Seth Tarachand Ramnath Charitable Ayurved Hospital
🇮🇳Pune, MAHARASHTRA, India
Dr Rekha Munjabhau Mahatme
Principal investigator
9422711869
rekha12mahatme@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.